(Total Views: 457)
Posted On: 02/13/2021 10:58:07 AM
Post# of 154194
I don't think this article is unfair. There are lots of things to be excited about,which he touches on.
Our financing remains a challenge. Not uncommon for a pre revenue biotech.
We've all seen the volatility that occurs when Fife sells.
I'd our CD12 results are as we hope, our financing will resolve instantly.
Our financing remains a challenge. Not uncommon for a pre revenue biotech.
We've all seen the volatility that occurs when Fife sells.
I'd our CD12 results are as we hope, our financing will resolve instantly.
(4)
(0)
